What is the FDA doing to streamline regulation and speed innovations to market? Larry Brilliant of the Skoll Global Threats Fund interviews Peggy Hamburg, Commissioner of the FDA at TEDMED 2012.
What is the FDA doing to streamline regulation and speed innovations to market? Larry Brilliant of the Skoll Global Threats Fund interviews Peggy Hamburg, Commissioner of the FDA at TEDMED 2012.

Sign up to receive the Orpyx Review
